Publications by authors named "A M Orjuela"

Article Synopsis
  • POCOP-Ni(II) pincer compounds, initially studied for their catalytic properties, were evaluated for their anticancer and antioxidant activities in this research.
  • Four specific POCOP-Ni(II) complexes derived from phloroglucinol showed significant cytotoxicity against various cancer cell lines, with IC values between 2.43 and 7.85 μM.
  • The study also employed techniques like single-crystal X-ray diffraction to analyze molecular structures and suggested that these complexes can intercalate with DNA, indicating potential mechanisms for their therapeutic effects.
View Article and Find Full Text PDF

Background: Carotenoids, potent antioxidants in fruits and vegetables, have recently garnered attention for their potential therapeutic effects against neurodegenerative diseases. This study focuses on the interaction and anti-aggregation properties of conventional and unconventional carotenoids found in red mamey fruit, a nutraceutical fruit that is a rich source of these compounds.

Objective: To assess computational the interaction between of amyloid-β (Aβ) peptide with a set of carotenoids and three carotenoids previously explored in experimental assays as well as to assess ADMET prediction of carotenoids selected by computational analysis results.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the effectiveness and toxicity of two treatments, rituximab (RTX) and cyclophosphamide (CYC), for pediatric patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).
  • It analyzes data from 104 patients and finds no significant difference in remission rates or severe adverse events between the two treatment groups.
  • Limitations of the study include the lack of standardized treatment protocols and the retrospective nature of the analysis.
View Article and Find Full Text PDF

Background: Lupus nephritis (LN) is a very severe manifestation of lupus. There is no consensus on which treatment goals should be achieved to protect kidney function in children with LN.

Methods: We retrospectively analyzed trends of commonly used laboratory biomarkers of 428 patients (≤ 18 years old) with biopsy-proven LN class ≥ III.

View Article and Find Full Text PDF
Article Synopsis
  • * A case report describes a 15-year-old male kidney transplant recipient who developed malakoplakia after experiencing recurrent diarrhea, confirmed through various tests and a colonoscopy.
  • * The patient initially responded well to trimethoprim-sulfamethoxazole but faced a recurrence after 9 months, leading to a change in treatment to oral gentamicin, which resulted in remission.
View Article and Find Full Text PDF